{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:18:28Z","timestamp":1707524308145},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,3]]},"DOI":"10.7759\/cureus.17696","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T20:03:09Z","timestamp":1630699389000},"source":"Crossref","is-referenced-by-count":1,"title":["Neovascular Glaucoma Progress and Impact of Therapeutic Intervention in Saudi Arabia"],"prefix":"10.7759","author":[{"given":"Khalid","family":"AlRubaie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Albahlal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tariq","family":"Alzahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak P","family":"Edward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv B","family":"Khandekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-016-0051-x","article-title":"Neovascular glaucoma: a review","volume":"2","author":"Rodrigues GB","year":"2016","unstructured":"Rodrigues GB, Abe RY, Zangalli C, et al.. Neovascular glaucoma: a review. Int J Retina Vitreous. 2016, 2:26. 10.1186\/s40942-016-0051-x","journal-title":"Int J Retina Vitreous"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1016\/S0161-6420(98)92782-8","article-title":"Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma","volume":"105","author":"Tripathi RC","year":"1998","unstructured":"Tripathi RC, Lixa J, Tripathi BJ, Chalam KV, Adamis AP. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology. 1998, 105:232-237.","journal-title":"Ophthalmology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2015.04.003","article-title":"Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: a review","volume":"60","author":"Kim M","year":"2015","unstructured":"Kim M, Lee C, Payne R, Yue BY, Chang JH, Ying H. Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: a review. Surv Ophthalmol. 2015, 60:524-535. 10.1016\/j.survophthal.2015.04.003","journal-title":"Surv Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1997.01100150488006","article-title":"Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group","volume":"115","year":"1997","unstructured":"Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol. 1997, 115.486-491. 10.1001\/archopht.1997.01100150488006","journal-title":"Arch Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(76)90292-0","article-title":"Preliminary report on effects of photocoagulation therapy","volume":"81","author":"Diabetic Retinopathy Study Research Group","year":"1976","unstructured":"Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol. 1976, 81:383-396. 10.1016\/0002-9394(76)90292-0","journal-title":"Am J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(80)35122-1","article-title":"Treatment of neovascular glaucoma with transscleral panretinal cryotherapy","volume":"87","author":"May DR","year":"1980","unstructured":"May DR, Bergstrom TJ, Parmet AJ, Schwartz JG. Treatment of neovascular glaucoma with transscleral panretinal cryotherapy. Ophthalmology. 1980, 87:1106-1111. 10.1016\/S0161-6420(80)35122-1","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2006.00731.x","article-title":"Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma","volume":"84","author":"Silva Paula J","year":"2006","unstructured":"Silva Paula J, Jorge R, Alves Costa R, Rodrigues Mde L, Scott IU. Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma. Acta Ophthalmol Scand. 2006, 84:556-557. 10.1111\/j.1600-0420.2006.00731.x","journal-title":"Acta Ophthalmol Scand"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.3928\/1542-8877-20060301-11","article-title":"Intravitreal bevacizumab in a patient with neovascular glaucoma","volume":"37","author":"Kahook MY","year":"2006","unstructured":"Kahook MY, Schuman JS, Noecker RJ. Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2006, 37:144-146.","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.06.066","article-title":"Intravitreal bevacizumab (Avastin\u00ae) in the treatment of neovascular glaucoma","volume":"142","author":"Iliev ME","year":"2006","unstructured":"Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM. Intravitreal bevacizumab (Avastin\u00ae) in the treatment of neovascular glaucoma. Am J Ophthalmol. 2006, 142:1054-1056. 10.1016\/j.ajo.2006.06.066","journal-title":"Am J Ophthalmol"},{"key":"ref10","article-title":"Neovascular glaucoma: a serious secondary condition: because NVG can lead to total vision loss, timely recognition and intervention is imperative for your patients","volume":"151","author":"Borgman CJ","year":"2014","unstructured":"Borgman CJ. Neovascular glaucoma: a serious secondary condition: because NVG can lead to total vision loss, timely recognition and intervention is imperative for your patients. Rev Optom. 2014, 151:58-66.","journal-title":"Rev Optom"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2014.0108","article-title":"Beneficial effects of adjuvant intravitreal bevacizumab injection on outcomes of Ahmed glaucoma valve implantation in patients with neovascular glaucoma: systematic literature review","volume":"31","author":"Hwang HB","year":"2015","unstructured":"Hwang HB, Han JW, Yim HB, Lee NY. Beneficial effects of adjuvant intravitreal bevacizumab injection on outcomes of Ahmed glaucoma valve implantation in patients with neovascular glaucoma: systematic literature review. J Ocul Pharmacol Ther. 2015, 31:198-203. 10.1089\/jop.2014.0108","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/0974-9233.48860","article-title":"Neovascular glaucoma at king Khaled eye specialist hospital - etiologic considerations","volume":"16","author":"Al-Shamsi HN","year":"2009","unstructured":"Al-Shamsi HN, Dueker DK, Nowilaty SR, Al-Shahwan SA. Neovascular glaucoma at king Khaled eye specialist hospital - etiologic considerations. Middle East Afr J Ophthalmol. 2009, 16:15-19. 10.4103\/0974-9233.48860","journal-title":"Middle East Afr J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(84)34293-2","article-title":"Neovascular glaucoma: etiologic considerations","volume":"91","author":"Brown GC","year":"1984","unstructured":"Brown GC, Magargal LE, Schachat A, Shah H. Neovascular glaucoma: etiologic considerations. Ophthalmology. 1984, 91:315-320. 10.1016\/S0161-6420(84)34293-2","journal-title":"Ophthalmology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-76","article-title":"Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic","volume":"9","author":"Al-Daghri NM","year":"2011","unstructured":"Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Yousef M, Sabico SL, Chrousos GP. Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC Med. 2011, 9:76. 10.1186\/1741-7015-9-76","journal-title":"BMC Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/174135","article-title":"Prevalence, awareness, treatment, and control of hypertension among Saudi adult population: a national survey","volume":"2011","author":"Saeed AA","year":"2011","unstructured":"Saeed AA, Al-Hamdan NA, Bahnassy AA, Abdalla AM, Abbas MAF, Abuzaid LZ. Prevalence, awareness, treatment, and control of hypertension among Saudi adult population: a national survey. Int J Hypertens. 2011, 2011:174135. 10.4061\/2011\/174135","journal-title":"Int J Hypertens"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-012-2236-9","article-title":"Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma","volume":"251","author":"Tatsumi T","year":"2013","unstructured":"Tatsumi T, Yamamoto S, Uehara J, et al.. Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma. Graefes Arch Clin Exp Ophthalmol. 2013, 251:1355-1360. 10.1007\/s00417-012-2236-9","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)00775-8","article-title":"Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma","volume":"108","author":"Sivak-Callcott JA","year":"2001","unstructured":"Sivak-Callcott JA, O'Day DM, Gass JD, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. 2001, 108:1767-1776. 10.1016\/S0161-6420(01)00775-8","journal-title":"Ophthalmology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.06.066","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma","volume":"142","author":"Iliev ME","year":"2006","unstructured":"Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol. 2006, 142:1054-1056. 10.1016\/j.ajo.2006.06.066","journal-title":"Am J Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097%2FIIO.0b013e31821e5960","article-title":"Medical and surgical treatment of neovascular glaucoma","volume":"51","author":"Olmos LC","year":"2011","unstructured":"Olmos LC, Lee RK. Medical and surgical treatment of neovascular glaucoma. Int Ophthalmol Clin. 2011, 51:27-36. 10.1097%2FIIO.0b013e31821e5960","journal-title":"Int Ophthalmol Clin"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.02.045","article-title":"Intracameral bevacizumab for iris rubeosis","volume":"142","author":"Grisanti S","year":"2006","unstructured":"Grisanti S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz-Schmidt KU, Tuebingen Bevacizumab Study Group. Intracameral bevacizumab for iris rubeosis. Am J Ophthalmol. 2006, 142:158-160. 10.1016\/j.ajo.2006.02.045","journal-title":"Am J Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000327364","article-title":"Intracameral injection of bevacizumab for the treatment of neovascular glaucoma","volume":"226","author":"Wolf A","year":"2011","unstructured":"Wolf A, von Jagow B, Ulbig M, Haritoglou C. Intracameral injection of bevacizumab for the treatment of neovascular glaucoma. Ophthalmologica. 2011, 226:51-56. 10.1159\/000327364","journal-title":"Ophthalmologica"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2010.01.008","article-title":"Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab","volume":"149","author":"Saito Y","year":"2010","unstructured":"Saito Y, Higashide T, Takeda H, Murotani E, Ohkubo S, Sugiyama K. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab. Am J Ophthalmol. 2010, 149:964-972. 10.1016\/j.ajo.2010.01.008","journal-title":"Am J Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3928\/15428877-20080101-09","article-title":"Visual loss after transscleral diode laser cyclophotocoagulation for primary open-angle and neovascular glaucoma","volume":"39","author":"Pokroy R","year":"2008","unstructured":"Pokroy R, Greenwald Y, Pollack A, Bukelman A, Zalish M. Visual loss after transscleral diode laser cyclophotocoagulation for primary open-angle and neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2008, 39:22-29. 10.3928\/15428877-20080101-09","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/01.ijg.0000212270.27359.64","article-title":"Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma","volume":"15","author":"Elgin U","year":"2006","unstructured":"Elgin U, Berker N, Batman A, Simsek T, Cankaya B. Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma. J Glaucoma. 2006, 15:466-470. 10.1097\/01.ijg.0000212270.27359.64","journal-title":"J Glaucoma"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2008.11.015","article-title":"Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure","volume":"147","author":"Takihara Y","year":"2009","unstructured":"Takihara Y, Inatani M, Fukushima M, Iwao K, Iwao M, Tanihara H. Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. Am J Ophthalmol. 2009, 147:912-918. 10.1016\/j.ajo.2008.11.015","journal-title":"Am J Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e3181f3eb06","article-title":"Ahmed glaucoma valve implantation for neovascular glaucoma after vitrectomy for proliferative diabetic retinopathy","volume":"20","author":"Park UC","year":"2011","unstructured":"Park UC, Park KH, Kim DM, Yu HG. Ahmed glaucoma valve implantation for neovascular glaucoma after vitrectomy for proliferative diabetic retinopathy. J Glaucoma. 2011, 20:433-438. 10.1097\/IJG.0b013e3181f3eb06","journal-title":"J Glaucoma"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2011.0059","article-title":"Clinical outcomes and changes in aqueous vascular endothelial growth factor levels after intravitreal bevacizumab for iris neovascularization and neovascular glaucoma: a retrospective two-dose comparative study","volume":"28","author":"Sasamoto Y","year":"2012","unstructured":"Sasamoto Y, Oshima Y, Miki A, et al.. Clinical outcomes and changes in aqueous vascular endothelial growth factor levels after intravitreal bevacizumab for iris neovascularization and neovascular glaucoma: a retrospective two-dose comparative study. J Ocul Pharmacol Ther. 2012, 28:41-48. 10.1089\/jop.2011.0059","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2010.350","article-title":"Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series","volume":"129","author":"Kotecha A","year":"2011","unstructured":"Kotecha A, Spratt A, Ogunbowale L, dell'Omo R, Kulkarni A, Bunce C, Franks WA. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series. Arch Ophthalmol. 2011, 129:145-150. 10.1001\/archophthalmol.2010.350","journal-title":"Arch Ophthalmol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000000211","article-title":"Long-term outcomes after preoperative intravitreal injection of bevacizumab before trabeculectomy for neovascular glaucoma","volume":"25","author":"Kobayashi S","year":"2016","unstructured":"Kobayashi S, Inoue M, Yamane S, Sakamaki K, Arakawa A, Kadonosono K. Long-term outcomes after preoperative intravitreal injection of bevacizumab before trabeculectomy for neovascular glaucoma. J Glaucoma. 2016, 25:281-284. 10.1097\/IJG.0000000000000211","journal-title":"J Glaucoma"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107840","article-title":"IDF Diabetes Atlas: a review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018","volume":"157","author":"Thomas RL","year":"2019","unstructured":"Thomas RL, Halim S, Gurudas S, Sivaprasad S, Owens DR. IDF Diabetes Atlas: a review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018. Diabetes Res Clin Pract. 2019, 157:107840. 10.1016\/j.diabres.2019.107840","journal-title":"Diabetes Res Clin Pract"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3980%2Fj.issn.2222-3959.2015.03.22","article-title":"Outcomes of Ahmed valve surgery for refractory glaucoma in Dhahran, Saudi Arabia","volume":"8","author":"Alasbali T","year":"2015","unstructured":"Alasbali T, Alghamdi AA, Khandekar R. Outcomes of Ahmed valve surgery for refractory glaucoma in Dhahran, Saudi Arabia. Int J Ophthalmol. 2015, 8:560-564. 10.3980%2Fj.issn.2222-3959.2015.03.22","journal-title":"Int J Ophthalmol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.4103%2F0974-620X.111905","article-title":"Short term outcome of Ahmed glaucoma valve implantation in management of refractory glaucoma in a tertiary hospital in Oman","volume":"6","author":"Shah MR","year":"2013","unstructured":"Shah MR, Khandekar RB, Zutshi R, Mahrooqi R. Short term outcome of Ahmed glaucoma valve implantation in management of refractory glaucoma in a tertiary hospital in Oman. Oman J Ophthalmol. 2013, 6:27-32. 10.4103%2F0974-620X.111905","journal-title":"Oman J Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/50518-neovascular-glaucoma-progress-and-impact-of-therapeutic-intervention-in-saudi-arabia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:34Z","timestamp":1707506914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/50518-neovascular-glaucoma-progress-and-impact-of-therapeutic-intervention-in-saudi-arabia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.17696","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,3]]}}}